Achillion shares up; FDA lifts hold on hepatatis C drug

June 10, 2014 2:25 PM

1 0

Achillion Pharmaceuticals Inc. said Tuesday the U.S. Food and Drug Administration has removed the clinical hold on sovaprevir, the company’s experimental hepatitis C treatment.

The news comes amid heightened interest in makers of hepatitis C drugs, as the pharmaceutical industry bets that improved medicines for the liver disease represent a large, long-term market opportunity. Illustrating that demand, Merck & Co. /quotes/zigman/574389/delayed/quotes/nls/mrk MRK +0.22% o...

Also read: Senate Clears Bill to Ease FDA Drug and Device Approvals

Read more

To category page

Loading...